Llwytho...
Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
Ceftaroline is a new parenteral cephalosporin approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for the treatment of complicated skin and soft tissue infections (cSSTIs) including those due to methicillin-resistant Staphylococcus aureus (MRSA), and communi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ther Clin Risk Manag |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4396454/ https://ncbi.nlm.nih.gov/pubmed/25897241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S75412 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|